Mucin-carbohydrate directed monoclonal antibody

Area of Science:

• Immunology and Cancer Research
• Glycobiology and Biomarker Discovery

Background:

• Cancer-associated alterations in cell surface carbohydrate structures are critical targets for cancer diagnostics.
• Monoclonal antibodies (mAbs) offer high specificity for identifying such unique cancer biomarkers.

Purpose of the Study:

• To generate and characterize monoclonal antibodies that recognize cancer-associated alterations in glycoprotein carbohydrate structures.
• To identify specific carbohydrate epitopes on human colonic cancer cells for potential diagnostic applications.

Main Methods:

• Immunization of Balb/c mice with human colonic cancer cells (LS 180).
• Hybridoma production and screening for antibody binding to cancer cell glycoproteins.
• Characterization of antibody specificity against different cancer cell lines, glycolipids, and animal mucins.

Main Results:

• A hybridoma produced a monoclonal antibody that specifically binds to the carbohydrate moiety of mucin-type glycoproteins from LS 180 cells.
• The antibody demonstrated specificity, not binding to glycoproteins from SW 1116 cells or to glycolipids.
• Binding was observed with ovine and bovine submaxillary mucins, suggesting involvement of Neu5Ac α2-6GalNAc in the epitope.

Conclusions:

• A novel monoclonal antibody has been developed that recognizes a specific cancer-associated carbohydrate epitope on mucin-type glycoproteins.
• This antibody shows potential as a diagnostic tool for identifying specific types of colonic cancer based on aberrant glycosylation.